Company Filing History:
5 out of 839 
1 out of 548 
1 out of 390 
Years Active: 2006-2016
Title: Anna Radominska-Pandya: Innovator in Cannabinoid Research and Anti-Cancer Therapies
Introduction
Anna Radominska-Pandya is a prominent inventor based in Little Rock, AR (US). She has made significant contributions to the fields of cannabinoid research and cancer treatment. With a total of 6 patents, her work focuses on innovative solutions for pressing health issues.
Latest Patents
Among her latest patents is the invention titled "Use of the aminoalkylindole JWH-073-M4 and related compounds as neutral CB1 receptor antagonists for the treatment of alcoholism, drug abuse, obesity, and obesity-related diseases." This patent presents novel alkylindoles that bind tightly to cannabinoid receptors, acting as neutral antagonists for the cannabinoid 1 receptor and agonists for the cannabinoid 2 receptor. These compounds are particularly useful for treating alcoholism, drug abuse, and obesity. Another significant patent is "Anti-cancer nanoparticle compositions and methods of use," which encompasses a composition capable of delivering and expressing a nucleic acid encoding UDP-Glucuronosyltransferases, p53, or a combination thereof into a cell. This invention provides methods for treating tumors effectively.
Career Highlights
Anna has worked with esteemed institutions such as the University of Arkansas and the University of Kansas. Her research has garnered attention for its potential impact on public health and cancer treatment.
Collaborations
Throughout her career, Anna has collaborated with notable individuals, including Jeffery Moran and Alexandru S Biris. These partnerships have contributed to the advancement of her research and innovations.
Conclusion
Anna Radominska-Pandya is a trailblazer in her field, with a focus on cannabinoid research and anti-cancer therapies. Her innovative patents and collaborations highlight her commitment to addressing critical health challenges.